The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review ...

The Company expects to enroll approximately 200 biomarker positive patients for the final analysis sample ... financial resources to fund its operations through expected milestones; and other ...

The B Lab requires B Corps to meet rigorous standards and to recertify every three years. ACE's most recent recertification was in 2023. ACE's annual Impact Report showcases the power of unified ...

General and administrative (G&A) expenses were $12.4 million for the first quarter of 2025, which included $5.1 million of restructuring expenses in March 2025. Non-cash stock-based compensation ...

Proof-of-mechanism has been established for TNG260 based on pharmacodynamic data from on-treatment patient biopsies, with ...

Risk Factors of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), the section titled Part I, Item 2, Management’s Discussion and Analysis of ...

This measure highlights performance ... based on currently available operating, financial and competitive information. Examples of forward-looking statements include all matters that are not ...

"They can do what wild animals do best — adapt and survive." New report reveals promising changes in US state's gray wolf ...

will report first quarter 2025 financial results and recent business highlights after the market close on Wednesday, May 14, 2025. CytoSorbents Corporation (NASDAQ: CTSO) is a leader in the ...

Navy Federal Credit Union's recently released 2024 Member Giveback Study highlights value of membership by banking with the not-for-profit, member owned credit union. Members earned and saved a total ...